Highlights

  • Levitee Labs was founded in 2020, and went public in July 2021. It is a Vancouver-based company focused on the emerging psychedelic sector. Through a network of recently acquired operating mental health/addiction clinics, and specialized pharmacies, the company intends to introduce novel psychedelic treatments and medications, upon legalization of psychedelics. Although difficult to speculate on the timeline of legalization, we are expecting Health Canada to grant certain psychedelic substances, like MDMA and psilocybin, a “breakthrough therapy” designation in the next one to three years. This designation will allow practitioners to administer and prescribe psychedelic drugs to treat mental health/addiction issues.
        • This report is currently available to premium subscribers – Free subscribers will gain access on November 15th, 2021
          Join as a FREE member and get our research report delivered straight to your inbox, with a seven-day delay

Visit Levitee Labs Inc. page for more research, discussion boards and to like, and share.


Are you enjoying the highlights?

Discover the company's fair value estimate from our certified analysts, identify potential risks, and explore exciting upcoming catalysts in our detailed report.

Already a member? Sign In